metoprolol has been researched along with Central Nervous System Disease in 2 studies
Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kirk, CA | 1 |
| Cove-Smith, R | 1 |
| Dimenäs, E | 1 |
| Dahlöf, C | 1 |
1 review available for metoprolol and Central Nervous System Disease
| Article | Year |
|---|---|
Tolerability and well-being with metoprolol in a controlled release (CR/ZOK) formulation: a review article.
Topics: Central Nervous System Diseases; Delayed-Action Preparations; Drug Tolerance; Humans; Hypertension; | 1990 |
1 trial available for metoprolol and Central Nervous System Disease
| Article | Year |
|---|---|
A comparison between atenolol and metoprolol in respect of central nervous system side effects.
Topics: Atenolol; Central Nervous System Diseases; Double-Blind Method; Humans; Hypertension; Metoprolol | 1983 |